Lack of clinically significant pharmacological interactions between ticagrelor and enoxaparin or unfractionated heparin in healthy subjects.
What is known and Objective: Patients with acute coronary syndromes (ACS) receive several pharmacological therapies concomitantly, including antiplatelet and anticoagulant agents. As unfractionated heparin (UFH) activates platelets in vitro and in vivo, co-administration with an antiplatelet agent m...
| Published in: | Journal of Clinical Pharmacy & Therapeutics Vol. 37; no. 6; pp. 704 - 712 |
|---|---|
| Main Authors: | , |
| Format: | research tables/charts Journal Article |
| Published: |
Wiley-Blackwell
Dec2012
|
| Online Access: | View this record in EBSCOhost |